VolitionRx Past Earnings Performance

Past criteria checks 0/6

VolitionRx's earnings have been declining at an average annual rate of -15.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 68.7% per year.

Key information

-15.3%

Earnings growth rate

-1.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate68.7%
Return on equityn/a
Net Margin-2,323.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?

Mar 17
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?

This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)

Feb 10
This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)

Revenue & Expenses Breakdown

How VolitionRx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:VNRX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241-301516
30 Jun 241-321618
31 Mar 241-351719
31 Dec 231-351720
30 Sep 231-341818
30 Jun 231-331619
31 Mar 230-311717
31 Dec 220-301715
30 Sep 220-311815
30 Jun 220-302012
31 Mar 220-281713
31 Dec 210-271513
30 Sep 210-241214
30 Jun 210-21815
31 Mar 210-21715
31 Dec 200-20715
30 Sep 200-19613
30 Jun 200-19613
31 Mar 200-18612
31 Dec 190-16610
30 Sep 190-17611
30 Jun 190-17611
31 Mar 190-18611
31 Dec 180-18711
30 Sep 180-18710
30 Jun 180-17710
31 Mar 180-1679
31 Dec 170-1578
30 Sep 170-1468
30 Jun 170-1368
31 Mar 170-1358
31 Dec 160-1258
30 Sep 160-1257
30 Jun 160-1147
31 Mar 160-1046
31 Dec 150-1046
30 Sep 150-836
30 Jun 150-1135
31 Mar 150-834
31 Dec 140-824
30 Sep 140-823
30 Jun 140-323
31 Mar 140-523

Quality Earnings: VNRX is currently unprofitable.

Growing Profit Margin: VNRX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VNRX is unprofitable, and losses have increased over the past 5 years at a rate of 15.3% per year.

Accelerating Growth: Unable to compare VNRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VNRX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: VNRX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies